Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000735186 | SCV000863389 | uncertain significance | not provided | 2018-09-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001493164 | SCV001697786 | likely benign | Wolman disease | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002397520 | SCV002713544 | likely benign | Cardiovascular phenotype | 2021-05-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004535886 | SCV004715409 | likely benign | LIPA-related disorder | 2021-11-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |